Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
COVID-19 Ripple Effect on Auto Insurance Market
After months of sheltering in place, it should come as no surprise that claims volumes are down.
Workers' Comp
News Release
The Self Insurer: Work Comp's Virtual Touch
By Bruce Shutan, The Self Insurer
Workers' Comp
Article
What COVID-19 Is Teaching Us About Mental Health
Pandemic anxiety, depression and isolation gives us a taste of what employees face in overcoming a work injury Americans have come a long
Mitchell
Article
Guide to Selecting an Electronic Payments Vendor
The workers’ compensation and auto casualty industries today are still in most cases, bogged down by paper.
Workers' Comp
Blog
Introducing Networks 2.0: Part Three
The best companies want workers back on the jobPayers and the companies they represent are eager to get injured workers back on their feet
Workers' Comp
News Release
Genex's Podcast Strikes Gold at Communicator Awards
‘Inside Workers' Comp' receives top honor from major communications award program